ConductScience.org, home

Paper41798535

Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature.

Dananjaya R and 6 others. Cureus, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature. Papers, record 41798535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41798535

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature.
PubMed
Journal
Cureus
PubMed
Year
2026
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dananjaya RRyan
2Harahap ASAgnes S
3Sari TTTeny T
4Ilmana GGanda
5Chozie NANovie A
6Ardhiawan AVAmanda V
7Ham MFMaria F

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127740969ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature.Am J Surg Pathol2017https://conductscience.org/library/papers/27740969PubMed
234141790Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report.World J Clin Cases2021https://conductscience.org/library/papers/34141790PubMed
328665943Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.PLoS One2017https://conductscience.org/library/papers/28665943PubMed
433261174Hodgkin Reed-Sternberg-Like Cells in Non-Hodgkin Lymphoma.Diagnostics (Basel)2020https://conductscience.org/library/papers/33261174PubMed
535802834Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.Blood2022https://conductscience.org/library/papers/35802834PubMed
639906668Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review.Front Oncol2024https://conductscience.org/library/papers/39906668PubMed
734151703Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.Leuk Lymphoma2021https://conductscience.org/library/papers/34151703PubMed
88122112Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.Science1994https://conductscience.org/library/papers/8122112PubMed
926781614ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.Int J Hematol2016https://conductscience.org/library/papers/26781614PubMed
1038573563ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression.J Hematop2024https://conductscience.org/library/papers/38573563PubMed
1135732829The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732829PubMed
1237935098NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.J Natl Compr Canc Netw2023https://conductscience.org/library/papers/37935098PubMed
1329455642Role and targeting of anaplastic lymphoma kinase in cancer.Mol Cancer2018https://conductscience.org/library/papers/29455642PubMed
1426418745FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.Elife2015https://conductscience.org/library/papers/26418745PubMed
1526630010Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26630010PubMed
1637773318ALK fusions in the pan-cancer setting: another tumor-agnostic target?NPJ Precis Oncol2023https://conductscience.org/library/papers/37773318PubMed
1738572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1837333805The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends.Front Oncol2023https://conductscience.org/library/papers/37333805PubMed
1936943241Current Approach to Undifferentiated Neoplasms, With Focus on New Developments and Novel Immunohistochemical Stains.Arch Pathol Lab Med2023https://conductscience.org/library/papers/36943241PubMed
2022474449Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma.Adv Hematol2012https://conductscience.org/library/papers/22474449PubMed

See all 43 referencesDownload CSV of references

Genes43

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADA251816PubTator's text mininghttps://conductscience.org/library/genes/51816NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ALKAL1389658PubTator's text mininghttps://conductscience.org/library/genes/389658NCBI Gene
ALKAL2285016PubTator's text mininghttps://conductscience.org/library/genes/285016NCBI Gene
CD1A909PubTator's text mininghttps://conductscience.org/library/genes/909NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CLTC1213PubTator's text mininghttps://conductscience.org/library/genes/1213NCBI Gene
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
DNTT1791PubTator's text mininghttps://conductscience.org/library/genes/1791NCBI Gene
ENO22026PubTator's text mininghttps://conductscience.org/library/genes/2026NCBI Gene
FUT42526PubTator's text mininghttps://conductscience.org/library/genes/2526NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
IRF43662PubTator's text mininghttps://conductscience.org/library/genes/3662NCBI Gene
KIT3815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene

See all 43 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41798535

GET https://conductscience.org/api/papers/v1/41798535/references?page=2